Coopersmith, Craig M.
De Backer, Daniel http://orcid.org/0000-0001-9841-5762
Deutschman, Clifford S.
Ferrer, Ricard
Lat, Ishaq
Machado, Flavia R.
Martin, Greg S.
Martin-Loeches, Ignacio
Nunnally, Mark E.
Antonelli, Massimo
Evans, Laura E.
Hellman, Judith
Jog, Sameer
Kesecioglu, Jozef
Levy, Mitchell M.
Rhodes, Andrew
Funding for this research was provided by:
European Society of Intensive Care Medicine
Society of Critical Care Medicine
Article History
Received: 6 February 2018
Accepted: 11 April 2018
First Online: 3 July 2018
Compliance with ethical standards
:
: Dr. DeBacker is immediate past president of the European Society of Intensive Care Medicine and has received consulting fees from Edwards Lifesciences, Fresenius Kabi, and Grifols. Dr. Deutschman is a consultant for Enlivix Therapeutix LTD. Dr. Ferrer Roca received honoraria from Toray, MSD, Pfizer and Grifols. Dr. Martin serves on a medical advisory board for Edwards Lifesciences and Grifols. Dr. Antonelli is president of the European Society of Intensive Care Medicine and received honoraria from Pfizer, Toray, Orion, and Air liquid. Dr. Evans is the current co-chair of the Surviving Sepsis Campaign guidelines committee. Dr. Kesecioglu is president-elect of the European Society of Intensive Care Medicine and has received honorarium from Xenios AG. Professor Rhodes is the current co-chair of the Surviving Sepsis Campaign guidelines committee.